These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19467574)

  • 21. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
    De Keyser J; Steen C; Mostert JP; Koch MW
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
    Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
    Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of inflammation induced tissue injury in multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2008 Nov; 274(1-2):45-7. PubMed ID: 18495163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system involvement in functional gastrointestinal disorders.
    Van Oudenhove L; Demyttenaere K; Tack J; Aziz Q
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):663-80. PubMed ID: 15324706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal activity in developing cat alpha-motor axons under normal conditions and during retrograde axonal transport of horseradish peroxidase.
    Gatzinsky KP; Berthold CH; Fabricius C
    J Comp Neurol; 1991 Oct; 312(4):599-609. PubMed ID: 1722223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC; Hughes P; Perry VH
    Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast axonal transport alterations in amyotrophic lateral sclerosis (ALS) and in parathyroid hormone (PTH)-treated axons.
    Breuer AC; Atkinson MB
    Cell Motil Cytoskeleton; 1988; 10(1-2):321-30. PubMed ID: 2460259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ; Wolswijk G; Bö L; van der Valk P; Polman CH; Troost D; Aronica E
    Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G; Balesar R
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensory-motor and genito-sphincter dysfunctions in multiple sclerosis.
    Gallien P; Robineau S
    Biomed Pharmacother; 1999 Sep; 53(8):380-5. PubMed ID: 10554672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple sclerosis].
    ELSTE R
    Hippokrates; 1951 May; 22(10):276-7. PubMed ID: 14849984
    [No Abstract]   [Full Text] [Related]  

  • 37. Correction: imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0123142. PubMed ID: 25849593
    [No Abstract]   [Full Text] [Related]  

  • 38. Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation.
    Errea O; Moreno B; Gonzalez-Franquesa A; Garcia-Roves PM; Villoslada P
    J Neuroinflammation; 2017 Oct; 14(1):206. PubMed ID: 29061147
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple sclerosis: Coagulation factors could mediate neuroinflammation in multiple sclerosis.
    Malkki H
    Nat Rev Neurol; 2016 Dec; 12(12):679. PubMed ID: 27811918
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple Sclerosis and Autoimmunity: A Veiled Relationship.
    Barkhane Z; Elmadi J; Satish Kumar L; Pugalenthi LS; Ahmad M; Reddy S
    Cureus; 2022 Apr; 14(4):e24294. PubMed ID: 35607574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.